Compliance & Ethics

AML Net Widens in Malta as Private Trustees Face 2026 Beneficial Ownership Deadline

For years, Malta’s beneficial ownership reporting regime has kept a watchful eye on professional trustees. Now, the net has widened. Private trustees, the individuals who quietly manage trusts outside of a professional setup, are being pulled into the same regulatory framework, with new obligations that promise to shake up how transparency in the sector is enforced.

Amazon Hit with Record $2.5 Billion Settlement Over Prime Subscription ‘Traps’

In what officials are calling a landmark victory for consumers, the Federal Trade Commission (FTC) has extracted a historic $2.5 billion settlement from Amazon over allegations that the e-commerce giant misled millions into unwanted Prime subscriptions and intentionally made it difficult to cancel them.

States Challenge Capital One Settlement as ‘Inadequate’

California Attorney General Rob Bonta has joined a coalition of 17 other state attorneys general in urging a federal court to reject Capital One’s proposed $425 million settlement in a multidistrict class action, arguing that it does not adequately compensate consumers who lost nearly $3 billion in potential interest earnings.

Altaroc Partners & Its Leaders Fined €1.3 Million Over Compliance Failings

France’s markets watchdog has come down hard on Altaroc Partners, handing the asset management firm and two of its top executives fines totaling €1.3 million after uncovering a pattern of governance and compliance missteps.

Swiss & UK Regulators Forge Closer Ties in Financial Services

Swiss and British regulators are tightening the knot on financial services cooperation, giving markets and clients a clearer sense of what to expect as cross-border rules evolve.

Sanofi Ordered to Pay €150.7 Million in Anti-Competition Ruling

Sanofi has been ordered to pay €150.7 million ($177.1 million) in damages to France’s national health insurance fund (CNAM) after a Paris appeals court found the drugmaker engaged in anti-competitive practices to protect sales of its anti-clotting drug Plavix, Reuters first reported.

Optus Hit With $65 Million Penalty for Exploitative Sales Practices

Optus has been dealt a major blow in the Federal Court, ordered to pay $65 million (AUD 100 million) after admitting it engaged in unconscionable conduct by selling mobile phones and plans to vulnerable Australians who often could not afford, use, or understand them.